C3 ( CTHR ) Diamond in the rough? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : C3 ( CTHR ) Diamond in the rough?

CTHR 0.200

0.0%

Jan 16 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Leslie S. Feinberg who wrote (125)	7/21/1998 9:07:00 AM
From: Rob LeVine	Read Replies (2) of 226

After reading Gigi's response I feel like the cloud on a sunny day. I asked my jeweler friend for clarification on the saturation comment. (All following sentences should be prefaced with 'He said...') The CZ reached market saturation years ago. When they first came out they were $25-$30 per stone and now they are $.50-$.75 per stone. Also, he feels that the moissenite will not be sold to any of the higher end jewelers (in fact he even drew the line below Zales). He feels that the stones will only go to places like QVC and similar entities. Not that I'd be proud of it, but if I could get something sold on QVC I'd do it. Something I should've mentioned before was that this jeweler is a jeweler in a small affluent town. He might not realize that there are a lot of people out there who actually buy 'fine jewelery' at Sears. - Rob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next